Remind your patients to get breast cancer screenings
Poles, G.
Pennsylvania Medicine 103(3): 10
2000
ISSN/ISBN: 0031-4595 PMID: 10765638 Document Number: 515379
Document emailed within 1 workday
Related Documents
Andersson, I.; Rydén, S.; Karlberg, I. 1995: The quality of mammography scrutinized. Ongoing control mass screenings for breast cancer is necessary Lakartidningen 92(35): 3106-3109Curioso, W.H.; Quistberg, D.Alex.; Cabello, R.; Gozzer, E.; Garcia, P.J.; Holmes, K.K.; Kurth, A.E. 2009: "It's time for your life": How should we remind patients to take medicines using short text messages? AMIA .. Annual Symposium Proceedings. AMIA Symposium 2009: 129-133
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Crivellari, D. 2002: Results of adjuvant treatments in breast cancer patients over 70 years old: the IBCSG experience. International Breast Cancer Study Group Tumori 88(1 Suppl. 1): S81-S82
Ansquer, Y.; Gautier, C.; Fourquet, A.; Asselain, B.; Stoppa-Lyonnet, D. 1998: Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group Lancet 352(9127): 541
Hooning, M.J.; van Dongen, J.A.; Went, G. 1991: Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation Netherlands Journal of Surgery 43(4): 102-104
Abdalla, I.; Thisted, R.A.; Heimann, R. 2000: The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy Cancer Journal 6(4): 266-272
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. I. Prognostic factors in patients with node-negative (N0) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 159-163
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. II. Prognostic factors in patients with node-positive (N1-3) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 165-170
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Li, Y.-h.; Tie, J.; Wu, H.; Li, X.-f.; Xu, B.; Cai, Y. 2013: Clinical observation of accelerated partial-breast intensity-modulated radiotherapy in patients with early-stage breast cancer after breast-conserving surgery Zhonghua Yi Xue Za Zhi 93(12): 924-926
Schultz, D.C.; Bazel, S.; Wright, L.M.; Tucker, S.; Lange, M.K.; Tachovsky, T.; Longo, S.; Niedbala, S.; Alhadeff, J.A. 1994: Western blotting and enzymatic activity analysis of cathepsin D in breast tissue and sera of patients with breast cancer and benign breast disease and of normal controls Cancer Research 54(1): 48-54
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Taguchi, T.; Koyama, H.; Yayoi, K.; Wada, T.; Takatsuka, Y.; Sonoo, H.; Morimoto, K.; Tominaga, T.; Abe, R.; Enomoto, K. 1995: Long-term clinical study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 495-508
Palencia, C.; Wicke, L.; Kärcher, K.H.; Gitsch, E.; Hernuss, P.; Steffen, C. 1976: Studies on the immune status of patients with operated and irradiated cervical and breast cancer. III. Comparative investigation of the immune status of patients with breast cancer treated by operation and irradiation and of patients with cervical cancer treated either by operation or irradiation Wiener Klinische Wochenschrift 88(15): 495-501
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
Bergkvist, L.; Träff, M.; Strand, E.; Norlin-Mellgren, E. 1994: A breast clinic staffed by nurses. Psychosocial support to patients with breast cancer Lakartidningen 91(20): 2028-2030
Tangkaratt, S. 2004: Mammographic findings in breast cancer patients, who were treated with breast conserving therapy Journal of the Medical Association of Thailand 87(12): 1439-1443
Zhu, Z.R.; Parviainen, M.; Männistö, S.; Pietinen, P.; Eskelinen, M.; Syrjänen, K.; Uusitupa, M. 1995: Vitamin a concentration in breast adipose tissue of breast cancer patients Anticancer Research 15(4): 1593-1596
Mannell, A. 2005: Breast-conserving therapy in breast cancer patients--a 12-year experience South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie 43(2): 28-30; Discussion 30, 32